Mark Fischer-colbrie BA, MBA

Mr. Fischer-Colbrie became CEO of Labcyte in 2008. He has more than 30 years of experience in launching novel diagnostics, medical devices, therapeutics and high technology products for growth companies, building from start-up through IPO and beyond.

Prior to joining Labcyte, Mr. Fischer-Colbrie was CFO and head of Business Development at a women’s health care start-up company, which went public in December 2004, and was subsequently sold for $450 million. Mr. Fischer-Colbrie was the inventor on 4 patents and 6 patent applications. Mr. Fischer-Colbrie was CFO for nine years at a startup vision correction company that subsequently went public. Earlier in his career, he held several positions including vice-president, finance, corporate controller and advanced technology business manager at a manufacturer of disk drives that grew from a start up to $1.2 billion in revenue and also went public.

Mr. Fischer-Colbrie holds a B.A. from Stanford University and an M.B.A. in Marketing and Finance from the University of California at Berkeley. He is currently Chairman of the Board of the Juvenile Diabetes Research Foundation (JDRF). Mr. Fischer-Colbrie is also a board member of the Analytical, Life Science & Diagnostic Association (ALDA), an industry association. He was honored to be selected as National EY Entrepreneur Of The Year 2013 Life Sciences Finalist and Northern California EY Entrepreneur Of The Year 2013 Life Sciences Winner.